| 30.09 14:02 | dpa-AFX: Prime Medicine Inks Strategic Research Collaboration And License Agreement With Bristol Myers Squibb |
| 30.09 13:43 | dpa-AFX: *PRIME MEDICINE, BRISTOL MYERS TO DEVELOP & COMMERCIALIZE PRIME EDITED EX VIVO T-CELL THERAPIES |
| 30.09 13:06 | dpa-AFX: Biotech Stocks Facing FDA Decision In October 2024 |
| 30.09 12:59 | dpa-AFX: Biotech Stocks Facing FDA Decision In October 2024 |
| 27.09 22:17 | MÄRKTE USA/Uneinheitlich nach Inflationsdaten - Dow mit Rekordhoch |
| 27.09 18:12 | MÄRKTE USA/Uneinheitlich nach Inflationsdaten - Dow mit Rekordhoch |
| 27.09 15:44 | MÄRKTE USA/Börsen nach Inflationsdaten gut behauptet gestartet |
| 27.09 15:08 | MÄRKTE USA/Wall Street nach Inflationsdaten etwas fester erwartet |
| 27.09 12:34 | MARKT USA/Börsen knapp behauptet erwartet - Inflationsdaten im Blick |
| 27.09 08:12 | dpa-AFX: *BRISTOL-MYERS BEI TG +4,3% VS NYSE - FDA-ZULASSUG FÜR COBENFY |
| 27.09 03:31 | dpa-AFX: Bristol Myers Squibb's COBENFY Gains FDA Approval For Adult Schizophrenia Treatment |
| 25.09 13:47 | dpa-AFX: 2seventy, Bristol Myers Discontinue Enrollment In Phase 3 KarMMa-9 Study |
| 25.09 13:13 | dpa-AFX: *2SEVENTY, BRISTOL MYERS TO DISCONTINUE ENROLLMENT IN PHASE 3 KARMMA-9 STUDY |
| 16.09 11:59 | dpa-AFX: *IMMATICS UNVEILS PROMISING PHASE 1 DATA FOR TCER IMA401 TARGETING MAGEA4/8 |
| 10.09 23:51 | dpa-AFX: *BRISTOL-MYERS SQUIBB CO. (BMY) DECLARES QUARTERLY DIVIDEND OF $ 0.60, RECORD DATE 10/4/2024 |
| 06.09 14:34 | dpa-AFX: Bristol-Myers Squibb To Present At Wells Fargo Healthcare Conference; Webcast At 9:30 AM ET |
| 05.09 18:09 | dpa-AFX: Bristol-Myers Squibb To Present At Morgan Stanley Healthcare Conference; Webcast At 1:05 PM ET |
| 05.09 02:59 | dpa-AFX: Merck's Winrevair Approved For Pulmonary Arterial Hypertension In Canada |
| 02.09 04:35 | dpa-AFX: Biotech Stocks Facing FDA Decision In September 2024 |
| 21.08 13:57 | dpa-AFX: Bristol Myers : FDA Accepts SBLA For First-Line Treatment Of Unresectable Hepatocellular Carcinoma |
|
|
